| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Approach to Antimicrobial Prophylaxis for Urology Procedures in the Era of Increasing Fluoroquinolone Resistance
|
Marino Sabo, Elizabeth
|
|
2014
|
48 |
3 |
p. 380-386
|
artikel
|
| 2 |
Association of Fentanyl With Neurodevelopmental Outcomes in Very-Low-Birth-Weight Infants
|
Lammers, Erin M.
|
|
2014
|
48 |
3 |
p. 335-342
|
artikel
|
| 3 |
Collaborative Practice Model Between Cardiologists and Clinical Pharmacists for Management of Patients With Cardiovascular Disease in an Outpatient Clinic
|
Ripley, Toni L.
|
|
2014
|
48 |
3 |
p. 412-419
|
artikel
|
| 4 |
Comments on Linezolid in Morbid Obesity
|
Boullata, Joseph I.
|
|
2014
|
48 |
3 |
p. 429-429
|
artikel
|
| 5 |
Comments on “Proton Pump Inhibitor–Associated Hypomagnesemia: What Do FDA Data Tell Us?”
|
Famularo, Giuseppe
|
|
2014
|
48 |
3 |
p. 431-431
|
artikel
|
| 6 |
Comparing Dosing of Basal Insulin Analogues Detemir and Glargine: Is It Really Unit-Per-Unit and Dose-Per-Dose?
|
Wallace, Juliet P.
|
|
2014
|
48 |
3 |
p. 361-368
|
artikel
|
| 7 |
Dolutegravir, a Second-Generation Integrase Inhibitor for the Treatment of HIV-1 Infection
|
Rathbun, R. Chris
|
|
2014
|
48 |
3 |
p. 395-403
|
artikel
|
| 8 |
Early Pharmacological Treatment of Delirium May Reduce Physical Restraint Use: A Retrospective Study
|
Michaud, Christopher J.
|
|
2014
|
48 |
3 |
p. 328-334
|
artikel
|
| 9 |
Early Symptom Improvement and Discontinuation of 5-α-Reductase Inhibitor (5ARI) Therapy in Patients With Benign Prostatic Hyperplasia (BPH)
|
Kruep, Eric J.
|
|
2014
|
48 |
3 |
p. 343-348
|
artikel
|
| 10 |
Erythema Multiforme Secondary to Dimenhydrinate in a Patient With Previous Similar Reactions to Pamabrom
|
Tan, Doreen Su-Yin
|
|
2014
|
48 |
3 |
p. 425-428
|
artikel
|
| 11 |
Evaluation of Dabigatran Exposures Reported to Poison Control Centers
|
Conway, Susan E.
|
|
2014
|
48 |
3 |
p. 354-360
|
artikel
|
| 12 |
Evaluation of Dabigatran Utilization and Risk Among Hospitalized Patients
|
Sidman, Eric
|
|
2014
|
48 |
3 |
p. 349-353
|
artikel
|
| 13 |
Evaluation of Impact of Statin Use on Development of CPK Elevation During Daptomycin Therapy
|
Berg, Melody L.
|
|
2014
|
48 |
3 |
p. 320-327
|
artikel
|
| 14 |
Fondaparinux as Alternative Anticoagulant to Warfarin or Low-Molecular-Weight Heparin for Recurrent Venous Thrombosis
|
Thachil, Jecko
|
|
2014
|
48 |
3 |
p. 420-424
|
artikel
|
| 15 |
Intravenous Metoprolol Versus Diltiazem for Rate Control in Noncardiac, Nonthoracic Postoperative Atrial Fibrillation
|
Personett, Heather A.
|
|
2014
|
48 |
3 |
p. 314-319
|
artikel
|
| 16 |
MenHibrix: A New Combination Meningococcal Vaccine for Infants and Toddlers
|
Hale, Sarah F.
|
|
2014
|
48 |
3 |
p. 404-411
|
artikel
|
| 17 |
Pediatric Exclusivity: Evolving Legislation and Novel Complexities within Pediatric Therapeutic Development
|
Rivera, Donna R.
|
|
2014
|
48 |
3 |
p. 369-379
|
artikel
|
| 18 |
Quantitative Drug Benefit-Risk Assessment: Utility of Modeling and Simulation to Optimize Drug Safety in Older Adults
|
Crentsil, Victor
|
|
2014
|
48 |
3 |
p. 306-313
|
artikel
|
| 19 |
Reply to Comments on “Subtherapeutic Linezolid Concentrations in a Patient With Morbid Obesity and Methicillin-Resistant Staphylococcus aureus Pneumonia: Case Report and Review of the Literature”
|
Muzevich, Katie M.
|
|
2014
|
48 |
3 |
p. 430-430
|
artikel
|
| 20 |
Response to “Proton Pump Inhibitor–Associated Hypomagnesemia: What Do FDA Data Tell Us?”
|
Luk, Chee Phun
|
|
2014
|
48 |
3 |
p. 432-432
|
artikel
|
| 21 |
Vandetanib for the Treatment of Medullary Thyroid Carcinoma
|
Cooper, Maryann R.
|
|
2014
|
48 |
3 |
p. 387-394
|
artikel
|
Tijdschrift beschrijving